Cart
sales@molnova.com
N-Me-aminopyrimidinone9
CAS No. 1356834-62-2
N-Me-aminopyrimidinone9( —— )
Catalog No. M21974 CAS No. 1356834-62-2
N-Me-aminopyrimidinone9 is a sodium channel antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 119 | In Stock |
|
| 5MG | 119 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 554 | In Stock |
|
| 200MG | 736 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Me-aminopyrimidinone9
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Me-aminopyrimidinone9 is a sodium channel antagonist.
-
DescriptionN-Me-aminopyrimidinone9 is a sodium channel antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1356834-62-2
-
Formula Weight303.4
-
Molecular FormulaC16H21N3OS?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCn1c(SCc2ccc(cc2)C(C)(C)C)nc(N)cc1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Flecainide
A class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias, works by blocking the Nav1.5 sodium channel in the heart.
-
VGSCs-IN-1
VGSCs-IN-1 is a potent VGSC inhibitor, a 2-piperazine analog of Riluzole that exhibits good blocking activity on Nav1.4.VGSCs-IN-1 can be used to study cellular excitability disorders.
-
AZD 7009 B
AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM.
